47192000: Meglumine amidotrizoate (substance)

SNOMED CT Concept\Substance\...

\Diagnostic substance (substance)\Contrast media (substance)\...

\Iodinated contrast media (substance)\Iodinated radiographic imaging contrast media\Ionic iodinated radiographic imaging contrast media\Ionic high-osmolality iodinated radiographic imaging contrast media\Amidotrizoate\Meglumine amidotrizoate

\Radiographic imaging contrast media (substance)\Iodinated radiographic imaging contrast media\Ionic iodinated radiographic imaging contrast media\Ionic high-osmolality iodinated radiographic imaging contrast media\Amidotrizoate\Meglumine amidotrizoate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Halogen and/or halogen compound\Iodine and/or iodine compound\Iodine compound\Iodinated contrast media (substance)\Iodinated radiographic imaging contrast media\Ionic iodinated radiographic imaging contrast media\Ionic high-osmolality iodinated radiographic imaging contrast media\Amidotrizoate\Meglumine amidotrizoate

\Organic compound\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Benzoic acid and/or benzoic acid derivative (substance)\Benzoate derivative (substance)\Amidotrizoate\Meglumine amidotrizoate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Meglumine amidotrizoate	Is a	Radiographic contrast media	false	Inferred relationship	Some
Meglumine amidotrizoate	Is a	Diagnostic substance (substance)	false	Inferred relationship	Some
Meglumine amidotrizoate	Is a	Radiopaque agent	false	Inferred relationship	Some
Meglumine amidotrizoate	Is a	Benzoate derivative (substance)	false	Inferred relationship	Some
Meglumine amidotrizoate	Is a	Amidotrizoate	true	Inferred relationship	Some
Meglumine amidotrizoate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Amidotrizoic acid	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing meglumine diatrizoate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some	1
Product containing meglumine diatrizoate and sodium diatrizoate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some	2
Diatrizoate meglumine 66%/sodium diatrizoate 10% solution 120mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 30% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine + diatrizoate sodium 520mg/80mg solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 527mg/iodipamide meglumine 268mg injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 50mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 10mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 300mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 180mg + iodine 85mg/mL (18%) injection solution 300mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 2000mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1000mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1250mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 150mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 20mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 200mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 100mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Diatrizoate meglumine 66%/sodium diatrizoate 10% solution 240mL bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Product containing meglumine diatrizoate in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some	1
Diatrizoate meglumine 66%/sodium diatrizoate 10% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
78660012	Meglumine diatrizoate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
78661011	Diatrizoate meglumine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2620869014	Meglumine amidotrizoate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3713672017	Meglumine amidotrizoate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
18201000188116	méglumine amidotrizoate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module